Anti-HIV Agents

"Anti-HIV Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.

Descriptor ID	D019380
MeSH Number(s)	D27.505.954.122.388.077.088
Concept/Terms	Anti-HIV Agents Anti-HIV Agents Agents, Anti-HIV Anti HIV Agents Anti-AIDS Agents Agents, Anti-AIDS Anti AIDS Agents Anti-HIV Drugs Anti HIV Drugs Drugs, Anti-HIV AIDS Drugs Drugs, AIDS Anti-AIDS Drugs Anti AIDS Drugs Drugs, Anti-AIDS

Below are MeSH descriptors whose meaning is more general than "Anti-HIV Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Anti-Infective Agents [D27.505.954.122]
Antiviral Agents [D27.505.954.122.388]
Anti-Retroviral Agents [D27.505.954.122.388.077]
Anti-HIV Agents [D27.505.954.122.388.077.088]

Below are MeSH descriptors whose meaning is related to "Anti-HIV Agents".

Below are MeSH descriptors whose meaning is more specific than "Anti-HIV Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Anti-HIV Agents" by people in this website by year, and whether "Anti-HIV Agents" was a major or minor topic of these publications.

Bar chart showing 141 publications over 26 distinct years, with a maximum of 10 publications in 2003 and 2010

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	2	1	3
2000	3	1	4
2002	5	1	6
2003	7	3	10
2004	3	3	6
2005	2	5	7
2006	3	2	5
2007	2	1	3
2008	7	1	8
2009	4	2	6
2010	10	0	10
2011	3	1	4
2012	2	2	4
2013	7	2	9
2014	1	3	4
2015	1	4	5
2016	2	3	5
2017	0	1	1
2018	4	3	7
2019	7	2	9
2020	3	1	4
2021	1	3	4
2022	6	0	6
2023	4	0	4
2024	5	1	6
2025	0	1	1

Below are the most recent publications written about "Anti-HIV Agents" by people in Profiles.

Ngo HHT, Pham TPT, Hoang HTT, Bui DH, Phan HTT, Nguyen QC, Duong TC, Bui HT, Nguyen HTT, Le MQT, Dang AD, McFarland W, Truong HM, Pham TH. Detection of Antiretroviral Drug-Resistant Mutations and HIV-1 Subtypes in Circulation Among Men Who Have Sex With Men, SEM Females, and Female Sex Workers: Results of Vietnam's HIV Sentinel Surveillance Plus System, 2018-2020. J Acquir Immune Defic Syndr. 2025 Jan 01; 98(1):29-36.

View in: PubMed
Dang MT, Le YN, Naz-McLean S, Vo NTT, Do PT, Doan LTT, Do NT, Nguyen MT, Phan AH, Dziuban EJ, Bhatia R, Cosimi L, Phan HTT, Pollack TM. Anticipated facilitators and barriers for long-acting injectable antiretrovirals as HIV treatment and prevention in Vietnam: a qualitative study among healthcare workers. BMC Infect Dis. 2024 Dec 25; 24(1):1462.

View in: PubMed
Coyle RP, Morrow M, Mann SC, Mainella V, Ellis SL, Schwab S, Coppinger C, Barker N, Ellison L, Zheng JH, Al Zuabi S, Alpert PE, Carnes TC, Buffkin DE, Chai PR, Bushman LR, Kiser JJ, MaWhinney S, Brooks KM, Anderson PL, Castillo-Mancilla JR. Tenofovir-Diphosphate and Emtricitabine-Triphosphate Adherence Benchmarks in Dried Blood Spots for Persons With HIV Receiving Tenofovir Alafenamide and Emtricitabine-Based Antiretroviral Therapy (QUANTI-TAF). Clin Infect Dis. 2024 Nov 22; 79(5):1233-1241.

View in: PubMed
Chai PR, Goodman GR, Mohamed Y, Bustamante MJ, Albrechta H, Lee JS, Glynn TR, Boland K, Hokayem J, Boyer EW, Rosen RK, Mayer KH, O'Cleirigh C. Leveraging A Digital Pill System to Understand Prevention-Effective Adherence to Oral Hiv Pre-Exposure Prophylaxis Among Men Who Have Sex with Men with Substance Use. AIDS Behav. 2024 Oct; 28(10):3373-3380.

View in: PubMed
Yu YJ, Schieber E, Janamnuaysook R, Wang B, Gunasekar A, MacDonell K, Getwongsa P, Kim D, Wongharn P, Phanuphak N. Barriers and facilitators to pre-exposure prophylaxis (PrEP) uptake and adherence among men who have sex with men (MSM) in Thailand: a qualitative study. AIDS Care. 2024 Aug; 36(8):1126-1134.

View in: PubMed
Midboe AM, Cave S, Shimada SL, Griffin AC, Avoundjian T, Asch SM, Gifford AL, McInnes DK, Troszak LK. Relationship Between Patient Portal Tool Use and Medication Adherence and Viral Load Among Patients Living with HIV. J Gen Intern Med. 2024 Feb; 39(Suppl 1):127-135.

View in: PubMed
Janamnuaysook R, Guo Y, Yu YJ, Phanuphak N, Kawichai S, MacDonell K, Jupimai T, Rongkavilit C, Wang B. Lived experiences with pre-exposure prophylaxis uptake and adherence among transgender women in Thailand: a qualitative study. Sex Health. 2024 Jan; 21.

View in: PubMed
Anderson JC, Boakye MDS, Draughon Moret J. Patient and Provider Decision Making About HIV Postexposure Prophylaxis Following Sexual Violence: A Qualitative Analysis. J Assoc Nurses AIDS Care. 2023 Nov-Dec 01; 34(6):566-581.

View in: PubMed
Donnell D, Gao F, Hughes JP, Hanscom B, Corey L, Cohen MS, Edupuganti S, Mgodi N, Rees H, Baeten JM, Gray G, Bekker LG, Hosseinipour M, Delany-Moretlwe S. Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women. J Int AIDS Soc. 2023 06; 26(6):e26118.

View in: PubMed
Yao TJ, Malee K, Zhang J, Smith R, Redmond S, Rice ML, Frederick T, Torre P, Mellins CA, Hoffman HJ, Williams PL. In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children. AIDS Patient Care STDS. 2023 03; 37(3):119-130.

View in: PubMed

People

Explore

Similar Concepts

Top Journals